title: Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner.
abstract: Influenza A virus (IAV) infection in the respiratory tract triggers robust innate and adaptive immune responses, resulting in both virus clearance and lung inflammation and injury. After virus clearance, resolution of ongoing inflammation and tissue repair occur during a distinct recovery period. B7 family co-stimulatory molecules such as CD80 and CD86 have important roles in modulating T cell activity during the initiation and effector stages of the host response to IAV infection, but their potential role during recovery and resolution of inflammation is unknown. We found that antibody-mediated CD86 blockade in vivo after virus clearance led to a delay in recovery, characterized by increased numbers of lung neutrophils and inflammatory cytokines in airways and lung interstitium, but no change in conventional IAV-specific T cell responses. However, CD86 blockade led to decreased numbers of FoxP3+ regulatory T cells (Tregs), and adoptive transfer of Tregs into αCD86 treated mice rescued the effect of the blockade, supporting a role for Tregs in promoting recovery after virus clearance. Specific depletion of Tregs late after infection mimicked the CD86 blockade phenotype, confirming a role for Tregs during recovery after virus clearance. Furthermore, we identified neutrophils as a target of Treg suppression since neutrophil depletion in Treg-depleted mice reduced excess inflammatory cytokines in the airways. These results demonstrate that Tregs, in a CD86 dependent mechanism, contribute to the resolution of disease after IAV infection, in part by suppressing neutrophil-driven cytokine release into the airways.
authors.affiliation: The Beirne B. Carter Center for Immunology Research, The University of Virginia, Charlottesville, Virginia, United States of America; Department of Pharmacology, The University of Virginia, Charlottesville, Virginia, United States of America.
authors.forename: Emily K
authors.initials: EK
authors.lastname: Moser
authors.affiliation: The Beirne B. Carter Center for Immunology Research, The University of Virginia, Charlottesville, Virginia, United States of America; Department of Microbiology, The University of Virginia, Charlottesville, Virginia, United States of America.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Hufford
authors.affiliation: The Beirne B. Carter Center for Immunology Research, The University of Virginia, Charlottesville, Virginia, United States of America; Department of Microbiology, The University of Virginia, Charlottesville, Virginia, United States of America; Department of Pathology, The University of Virginia, Charlottesville, Virginia, United States of America.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Braciale
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D051940:B7-2 Antigen / Q000276:immunology*; D005434:Flow Cytometry; D051858:Forkhead Transcription Factors / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009976:Orthomyxoviridae Infections / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D051940:B7-2 Antigen; C497965:Cd86 protein, mouse; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse